Get Real: Orbital’s Chris Bunniss On Real World Evidence’s Potential For OTC Innovation
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
You may also be interested in...
Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy.
The European Medicines Agency commits to exploring real-world data as part of its new Regulatory Science Strategy to 2025.
Virtual trials could be the answer to limitations placed on innovation by the coronavirus pandemic and help companies formulate new health claims relevant to a new generation of consumers, argued IQVIA Consumer Health during a recent webinar.